We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$7.07B
AUM Growth
-$2.18B
Cap. Flow
-$2.47B
Cap. Flow %
-34.87%
Top 10 Hldgs %
22.16%
Holding
3,861
New
1,138
Increased
540
Reduced
516
Closed
1,413

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MCK icon
McKesson
MCK
+$132M
3
TSLA icon
Tesla
TSLA
+$88.8M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$72.7M
5
CSCO icon
Cisco
CSCO
+$57.5M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Financials 10.47%
3 Healthcare 9.77%
4 Consumer Discretionary 8.51%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRNT.WS
2151
DELISTED
Granite Ridge Resources, Inc. Warrants to purchase Common Stock, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
GRNT.WS
$28K ﹤0.01%
+24,671
New +$26.3K
BGMS
2152
Bio Green Med Solution Inc
BGMS
$5.24M
$27K ﹤0.01%
+11
New +$40.6K
MTNB icon
2153
Matinas BioPharma
MTNB
$1.81M
$27K ﹤0.01%
1,091
+831
+320% +$27.6K
VEON icon
2154
VEON
VEON
$3.95B
$27K ﹤0.01%
2,227
-6,949
-76% -$74.7K
AFRIW icon
2155
Forafric Global PLC Warrants
AFRIW
$11.5M
$26K ﹤0.01%
38,393
OPGN
2156
DELISTED
OpGen, Inc
OPGN
$26K ﹤0.01%
+957
New +$35.2K
BLCM
2157
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$26K ﹤0.01%
+36,470
New +$36.1K
LABP
2158
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$26K ﹤0.01%
+5,256
New +$20.1K
ALVOW icon
2159
Alvotech Warrant
ALVOW
$25K ﹤0.01%
23,672
DHF
2160
BNY Mellon High Yield Strategies Fund
DHF
$172M
$25K ﹤0.01%
+11,931
New +$26.4K
RNWWW
2161
ReNew Energy Global PLC Warrant
RNWWW
$44.5K
$25K ﹤0.01%
33,292
BLPH
2162
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$25K ﹤0.01%
+28,035
New +$28.7K
AUID icon
2163
authID Inc
AUID
$10.6M
$24K ﹤0.01%
5,256
-4,379
-45% -$41.1K
NAMSW icon
2164
NewAmsterdam Pharma Warrant
NAMSW
$78.2M
$24K ﹤0.01%
+30,321
New +$25K
PAYOW
2165
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$24K ﹤0.01%
22,839
-17,081
-43% -$22K
ASPU
2166
DELISTED
ASPEN GROUP, INC.
ASPU
$24K ﹤0.01%
+78,509
New +$28.5K
GNLN icon
2167
Greenlane Holdings
GNLN
$1.23M
0
LCTX icon
2168
Lineage Cell Therapeutics
LCTX
$278M
$23K ﹤0.01%
+20,209
New +$25.5K
OGI
2169
Organigram Holdings
OGI
$139M
$23K ﹤0.01%
7,269
+3,003
+70% +$11.3K
RIBT
2170
DELISTED
RiceBran Technologies
RIBT
$23K ﹤0.01%
+31,220
New +$37.3K
FUBO icon
2171
FuboTV Inc
FUBO
$273M
$22K ﹤0.01%
+1,101
New +$40.3K
RKDA icon
2172
Arcadia Biosciences
RKDA
$1.52M
$22K ﹤0.01%
+2,080
New +$29.6K
SYRE icon
2173
Spyre Therapeutics
SYRE
$9.25B
$22K ﹤0.01%
+1,999
New +$35.9K
MIND icon
2174
MIND Technology
MIND
$46.2M
$21K ﹤0.01%
+4,645
New +$24.8K
HTT
2175
High Templar Tech Ltd
HTT
$391M
$21K ﹤0.01%
+23,000
New +$20.1K

Similar funds

HRT Financial's Q4 2022 Portfolio in Review

As of Q4 2022, HRT Financial held 3,861 positions worth $7.07B, down 24% from $9.25B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

HRT Financial withdrew a net $2.47B in Q4 2022, closing 1,413 positions and reducing 516 holdings. Its most notable exit was Duke Realty Corp., an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, HRT Financial opened a new position in Apple worth $206M.

  • HRT Financial's largest Q4 2022 buy was Apple: 1,584,749 shares worth $206M.
  • HRT Financial added most to Cisco in Q4 2022, an estimated $57.5M increase.
  • HRT Financial's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $628M.
  • HRT Financial fully exited Duke Realty Corp. in Q4 2022, selling an estimated $214M.
  • HRT Financial's ten largest holdings make up 22% of its $7.07B portfolio in Q4 2022.
  • HRT Financial opened 1,138 new positions and closed 1,413 in Q4 2022.
  • HRT Financial's portfolio value fell 24% quarter-over-quarter to $7.07B.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.